Institute of Wudang Traditional Chinese Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Department of Pharmacy, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Mol Diagn Ther. 2019 Aug;23(4):489-498. doi: 10.1007/s40291-019-00402-4.
Diabetes mellitus represents a chronic metabolic disorder characterized by impaired lipid homeostasis and carbohydrate metabolism, gradually leading to persistent hyperglycemia. The extracts of Rhodiola species are widely used as herbal medicine or dietary supplement in Asia, Europe and the United States. Salidroside, a p-hydroxyphenethyl-β-glucoside compound, is the main active ingredient of the Rhodiola root. Recently, various studies have suggested that Rhodiola and salidroside may have pharmacological properties that could be used in the treatment of diabetes, as studies have confirmed that AMP-activated protein kinase (AMPK) and AMPK-related signaling are connected with its beneficial effects. This review aims to summarize the research progress of Rhodiola and salidroside in the treatment of diabetes. A detailed summary of AMPK and AMPK-related signaling induced by Rhodiola and salidroside are discussed.
糖尿病是一种慢性代谢性疾病,其特征是脂质稳态和碳水化合物代谢受损,逐渐导致持续性高血糖。在亚洲、欧洲和美国,红景天属植物的提取物被广泛用作草药或膳食补充剂。红景天苷是一种对-羟苯乙基-β-葡萄糖苷化合物,是红景天根的主要活性成分。最近,各种研究表明,红景天和红景天苷可能具有药理学特性,可用于治疗糖尿病,因为研究证实,腺苷酸活化蛋白激酶(AMPK)和 AMPK 相关信号与它的有益作用有关。本综述旨在总结红景天和红景天苷在治疗糖尿病方面的研究进展。详细总结了红景天和红景天苷诱导的 AMPK 和 AMPK 相关信号。